These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 23616737)
21. Cefazolin in chronic hemodialysis patients: a safe, effective alternative to vancomycin. Fogel MA; Nussbaum PB; Feintzeig ID; Hunt WA; Gavin JP; Kim RC Am J Kidney Dis; 1998 Sep; 32(3):401-9. PubMed ID: 9740155 [TBL] [Abstract][Full Text] [Related]
22. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy. Nahata MC Chemotherapy; 1987; 33(4):302-4. PubMed ID: 3608631 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic drug monitoring of vancomycin in an obese patient with renal insufficiency. Abuhasna S; Al Jundi AH J Anaesthesiol Clin Pharmacol; 2011 Oct; 27(4):531-3. PubMed ID: 22096290 [TBL] [Abstract][Full Text] [Related]
24. Outcome assessment of minimizing vancomycin monitoring and dosing adjustments. Karam CM; McKinnon PS; Neuhauser MM; Rybak MJ Pharmacotherapy; 1999 Mar; 19(3):257-66. PubMed ID: 10221365 [TBL] [Abstract][Full Text] [Related]
25. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid. Stein GE; Wells EM Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic adjustment of gentamicin dosing in horses with sepsis. Sojka JE; Brown SA J Am Vet Med Assoc; 1986 Oct; 189(7):784-9. PubMed ID: 3771340 [TBL] [Abstract][Full Text] [Related]
27. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC Issaranggoon Na Ayuthaya S; Katip W; Oberdorfer P; Lucksiri A Int J Infect Dis; 2020 Mar; 92():151-159. PubMed ID: 31935538 [TBL] [Abstract][Full Text] [Related]
28. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy. Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472 [TBL] [Abstract][Full Text] [Related]
30. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients. Kraus DM; Dusik CM; Rodvold KA; Campbell MM; Kecskes SA Pediatr Infect Dis J; 1993 Sep; 12(9):713-8. PubMed ID: 8414796 [TBL] [Abstract][Full Text] [Related]
31. A Systematic Review of Vancomycin Dosing and Monitoring in Burn Patients. Carter BL; Damer KM; Walroth TA; Buening NR; Foster DR; Sood R J Burn Care Res; 2015; 36(6):641-50. PubMed ID: 25423436 [TBL] [Abstract][Full Text] [Related]
32. Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster. Guay DR; Vance-Bryan K; Gilliland S; Rodvold K; Rotschafer J J Clin Pharmacol; 1993 Oct; 33(10):918-22. PubMed ID: 8227461 [TBL] [Abstract][Full Text] [Related]
33. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness. Lopez SA; Mulla H; Durward A; Tibby SM Pediatr Crit Care Med; 2010 Mar; 11(2):267-74. PubMed ID: 19770786 [TBL] [Abstract][Full Text] [Related]
34. Individualized dosing of vancomycin in geriatric patients. Suchánková H; Lečbychová K; Strojil J; Fürst T Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941 [TBL] [Abstract][Full Text] [Related]
35. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium. Fantin B; Leclercq R; Arthur M; Duval J; Carbon C Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013 [TBL] [Abstract][Full Text] [Related]
36. Gentamicin and vancomycin removal by continuous venovenous hemofiltration. Thomson AH; Grant AC; Rodger RS; Hughes RL DICP; 1991 Feb; 25(2):127-9. PubMed ID: 2058183 [TBL] [Abstract][Full Text] [Related]
37. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients. Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384 [TBL] [Abstract][Full Text] [Related]
38. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration]. Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231 [TBL] [Abstract][Full Text] [Related]
39. Population Pharmacokinetics of Vancomycin in Pediatric Extracorporeal Membrane Oxygenation. Moffett BS; Morris J; Galati M; Munoz F; Arikan AA Pediatr Crit Care Med; 2018 Oct; 19(10):973-980. PubMed ID: 30063652 [TBL] [Abstract][Full Text] [Related]
40. [Individualized vancomycin dosing for a patient diagnosed as severe acute pancreatitis with concurrent extracorporeal membrane oxygenation and continuous veno-venous hemofiltration therapy: a case report]. He N; Yan YY; Ying YQ; Yi M; Yao GQ; Ge QG; Zhai SD Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):915-920. PubMed ID: 30337758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]